Clinical Study
Mobilization of Stem Cells Using G-CSF for Acute Ischemic Stroke: A Randomized Controlled, Pilot Study
Table 4
Leukocyte counts at baseline and maximum count during hospital stay and clinical score during baseline one month, six months, and 12 months.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
NIHSS: National Institutes of Health stroke scale, BI: Barthel index, mRS: modified ranking scale NIHSS score range from 0 to 42 (lower score represents better outcome and higher score represents worse outcome) BI score range from 0 to 100 (Higher score represents the better outcome and lower score represents the worse outcome) mRS score range from 0 to 6 (lower score represents better outcome and higher score represents worse outcome). |